• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Reducing Cardiovascular Events in Patients with T2D

Program Type

OnDemand

Credits

2 Contact Hour(s)

Release Date

Wednesday, March 13, 2019

Offline Date:

Sunday, March 13, 2022

ACPE Expiration Date

Sunday, March 13, 2022

Target Audience

Nurse, Pharmacist

Cost

$0.00

  • Overview

    Patients with diabetes are also much more likely to suffer from cardiovascular disease than those without diabetes. In fact, cardiovascular disease is the leading cause of death associated with diabetes. Findings from several recent clinical trials highlight the limitations of focusing exclusively on glycemic treatment goals for type 2 diabetes (T2D) and emphasize the need for cardiovascular risk reduction as well. Pharmacists are often the medical professional that patients reach out to for guidance and explanation on new pharmaco-therapy and individualized treatment. This educational opportunity will give pharmacists an in depth look at the clinical evidence behind the changes and opportunities for individualized treatment of T2D and in particular those with higher CVD risk to improve patient outcomes.

    Rating


    Handouts

    Slide Document:   19009H01_6pp.pdf
    Slide Document:   19009H01_2pp.pdf

    Financial Support By

    Novo Nordisk
  • Nurse

    Review the current treatment guidelines for T2D in patients at risk for cardiovascular events
    Outline the results of cardiovascular outcomes trials of antihyperglycemic therapies in patients with T2D.
    Compare and contrast evidence-based treatment options that optimize glycemic and reduce cardiovascular events in patients with type 2 diabetes.
    Identify approaches to communicate the potential cardiovascular benefits and risk of various treatment approaches for diabetes to patients and members of the healthcare team.


    Pharmacist

    Review the current treatment guidelines for T2D in patients at risk for cardiovascular events
    Outline the results of cardiovascular outcomes trials of antihyperglycemic therapies in patients with T2D.
    Compare and contrast evidence-based treatment options that optimize glycemic and reduce cardiovascular events in patients with type 2 diabetes.
    Identify approaches to communicate the potential cardiovascular benefits and risk of various treatment approaches for diabetes to patients and members of the healthcare team.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-19-009-H01-N

    Pharmacist 0798-0000-19-009-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.